The nurse is assessing a client with suspected appendicitis. Which finding is most indicative of this condition?

Choice A reason: Hepatorenal failure involves liver and kidney dysfunction, typically from chronic liver disease or shock. Elevated amylase and lipase, with pain and vomiting, point to pancreatic inflammation, not hepatorenal issues. Pancreatitis is more consistent with the client’s post-cholecystectomy presentation and lab findings.

Choice B reason: Biliary duct obstruction causes jaundice and elevated bilirubin, not amylase or lipase. Pain may radiate, but vomiting and fever with high pancreatic enzymes suggest pancreatitis, a known post-cholecystectomy complication, rather than a blocked bile duct, which lacks pancreatic enzyme elevation.

Choice C reason: Surgical site infection causes localized pain, erythema, and fever but not elevated amylase or lipase. Radiating pain and vomiting align with pancreatitis, not wound infection. Pancreatic enzyme elevation is specific to pancreatic inflammation, making infection less likely than pancreatitis in this scenario.

Choice D reason: Acute pancreatitis is characterized by elevated amylase and lipase, epigastric pain radiating to the back, vomiting, and fever. Post-cholecystectomy, bile duct manipulation or gallstone migration can trigger pancreatitis. These findings align perfectly with the client’s symptoms and lab results, making it the correct condition.

Choice A reason: Using a bronchodilator for sudden shortness of breath applies to rescue inhalers like albuterol, not maintenance bronchodilators (e.g., tiotropium) for COPD, which are used daily. This statement indicates misunderstanding, as maintenance inhalers prevent symptoms, not treat acute dyspnea.

Choice B reason: Thinner sputum is not a primary effect of bronchodilators, which relax airway smooth muscles to improve airflow in COPD. Mucolytics, not bronchodilators, reduce sputum viscosity. This statement reflects incorrect understanding, as bronchodilators target bronchoconstriction, not secretion consistency.

Choice C reason: Daily use of a maintenance bronchodilator, like tiotropium, is correct for COPD to prevent bronchospasm and maintain airway patency. This statement shows proper understanding, as consistent use reduces exacerbations and improves lung function, aligning with standard COPD management protocols.

Choice D reason: Using another inhaler between doses suggests confusion about maintenance versus rescue inhalers. Maintenance bronchodilators are used daily, not interspersed with others. This indicates misunderstanding, as proper scheduling is essential for effective COPD control with prescribed bronchodilators.